Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Motilal Oswal Business Cycle Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseMotilal OswalHDFC
NAV₹13.2352₹22.8170
NAV date20 Nov 202620 Nov 2026
History2.2 years3.1 years
Expense ratio2.5%2.1%
StarsNot rated★★★★★
Growth Score—93.90

Returns

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+6.95%+12.87%
3 months+1.44%+6.85%
6 months+17.34%+17.20%
YTD+4.05%+32.43%
1 year−1.31%+30.73%
3 years (CAGR)—+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch+10.87%+30.28%

Risk

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.6%
Sharpe—1.44
Sortino—2.64
Calmar—1.94
Return / risk—1.85
Deepest fall−25.03%−15.07%
Days to recover—133
Below its high−2.39%+0.00%

Against benchmark

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha—+6.36%
Beta—0.97
R²—85.0%
Up capture—106.7%
Down capture—74.4%
Tracking error—6.1%
Information ratio—0.97
Treynor—0.22

Consistency

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+24.01%+64.96%
Middle 1-year−0.06%+21.84%
Worst 1-year−12.70%+0.52%
1-year periods with a loss51.0%0.0%
Middle 3-year—+28.68%
Positive months—69.4%
Best day+4.39%+3.19%
Worst day−4.46%−3.62%
Worst 5% day−1.96%−1.50%
Positive days56.7%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Motilal Oswal Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+26.26%
1-year XIRR+17.40%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth